A clinical guide to the conditions that commonly co-occur with perimenopause, including thyroid disease, metabolic syndrome, mood disorders, sleep disturbance, and cardiovascular risk, with guidance on what to screen for and when to escalate care.
Learn how genetics and family history shape perimenopause timing, symptom severity, and treatment options. Evidence-based guidance from the HealthRX.com medical team, with citations to primary research.
A guideline-based treatment algorithm for perimenopause: first-line, second-line, and third-line options for vasomotor symptoms, cycle irregularity, mood disturbance, and bone protection, with dosing, evidence grades, and society recommendations.
Prediabetes and mental health disorders share overlapping biology, risk factors, and treatment gaps. Learn how depression, anxiety, and chronic stress drive glucose dysregulation, and what clinical guidelines say about screening and treating both.
A guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
A guide to exercise protocols for secondary hypogonadism, covering resistance training, HIIT, aerobic work, and how structured movement affects LH, FSH, and testosterone recovery.
An evidence-based treatment algorithm for tendinopathy covering first-line load management and eccentric exercise through third-line PRP, BPC-157, and surgical referral, with citations to primary RCTs and society guidelines.
Chest pain over a few minutes, sudden one-sided weakness, speech loss, severe shortness of breath, or fainting need an immediate 911 call, not a drive to the ER.
A decision framework for first-line management of established cardiovascular disease, covering antiplatelet therapy, statins, ACE inhibitors, beta-blockers, and the evidence for GLP-1 receptor agonists such as semaglutide in patients with cardiovascular disease and excess weight.
A guide to stopping testosterone replacement therapy for male hypogonadism safely, including tapering protocols, HPG axis recovery, and monitoring schedules backed by Endocrine Society guidelines.
Evidence-based strategies to prevent the return of menopause symptoms, protect bone density, support cardiovascular health, and sustain quality of life. prepared by the HealthRX.com Editorial Team.
Learn exactly how to prepare for your first clinical visit about menopause-related weight gain, what labs to request, which symptoms to track, and how HRT and GLP-1 medications fit into the treatment plan.
Menopause-related weight gain is frequently misattributed to aging or lifestyle alone. Learn which diagnoses are commonly missed, how to distinguish them, and what evidence-based treatments actually work.
How spouses, children, and household members can actively support metabolic syndrome management, covering shared lifestyle changes, communication strategies, and clinical evidence on family-based interventions.
Learn which obesity-related emergency symptoms require calling 911 immediately, including hypertensive crisis, pulmonary embolism, acute MI, and severe hypoglycemia. Written by the HealthRX.com medical team and reviewed by board-certified physicians.
Obesity is frequently misdiagnosed or its underlying drivers missed entirely. This clinical guide covers the secondary causes, comorbidities, and diagnostic blind spots every patient and clinician needs to know.
How partners and family members can support obesity treatment. Evidence-based strategies covering shared lifestyle change, emotional support, medication adherence, and what the guidelines say.
A guide to identifying, evaluating, and enrolling in the right OSA clinical trial, covering eligibility, trial phases, key studies like SURMOUNT-OSA, and how GLP-1 therapies are reshaping OSA research.
A guide to stopping CPAP, positional therapy, or GLP-1 treatment for OSA safely, including when re-testing is required, what guidelines say, and how weight loss changes the calculus.
A guide to first-line OSA treatment decisions, covering CPAP, positional therapy, oral appliances, weight-loss interventions including tirzepatide, and surgery, with AHI-based thresholds and society guideline citations.
A complete guide to preparing for your first OSA appointment, what to track, what questions to ask, and what diagnostic and treatment options to expect, including CPAP, weight-loss therapy, and FDA-approved tirzepatide.
Learn exactly when OSA treatment has failed, what AHI thresholds, symptom persistence, and adherence gaps define failure, and which evidence-based next steps apply.
Learn how partners and family members can actively support PCOS management, from lifestyle changes and fertility planning to emotional wellbeing and treatment decisions. Evidence-based guidance from the HealthRX.com medical team.
A guide to identifying, evaluating, and enrolling in perimenopause clinical trials, covering eligibility criteria, trial phases, HRT, non-hormonal options, and how to match your symptom profile to open studies.
A stage-by-stage guide to the real costs of perimenopause care, from early irregular cycles through late-stage vasomotor symptoms, including medication costs, lab work, and when to seek specialist care.
How partners and family members can support someone through perimenopause, including symptom education, communication strategies, and when to encourage professional care.
A decision framework for post-surgical recovery, covering evidence-based first-line interventions, pain management, nutrition, rehabilitation timing, and the current evidence on off-label peptide use including BPC-157 and TB-500.
Evidence-based strategies to prevent surgical recovery setbacks, including physical rehabilitation timelines, nutrition protocols, wound care, and the current evidence on off-label peptides like BPC-157 and TB-500.
Learn the red flags, clinical benchmarks, and evidence-based decision points that tell you when a second surgical opinion is medically warranted after elective or trauma surgery.
A guide to recognizing, diagnosing, and managing treatment failure in secondary hypogonadism, covering testosterone, enclomiphene, hCG, and next-step protocols backed by Endocrine Society guidelines and primary trial data.
A review of mechanistic research beyond LDL-lowering in established cardiovascular disease, covering inflammation, clonal hematopoiesis, gut microbiome signaling, Lp(a), and GLP-1 receptor agonists, with notes on evidence strength and what remains unproven.
A clinical comparison of established cardiovascular disease in children versus adults, covering etiology, presentation, diagnostics, treatment, and outcomes, with an explicit map of what is established, what is plausible, and what still needs verification.
A clinical deep-dive into rare and atypical presentations of male hypogonadism, including fertile eunuch syndrome, Kallmann syndrome variants, late-onset hypogonadism without classic symptoms, and medication-induced forms, with primary-source citations and practical diagnostic guidance.
A clinically detailed guide to the uncommon and misdiagnosed faces of menopause, including rare vasomotor variants, neurological symptoms, skin and joint changes, and premature ovarian insufficiency, with primary-source citations and guidance.
A deep dive into the latest science on why menopause drives weight gain, covering estrogen signaling, hypothalamic changes, gut microbiome shifts, brown adipose tissue dysfunction, and GLP-1 receptor interactions.
How common is metabolic syndrome worldwide? Epidemiology data, regional breakdowns, rising trends, diagnostic criteria, and clinical guidance from primary sources.
Metabolic syndrome affects 1 in 3 U.S. Adults and generates hundreds of billions in annual healthcare costs. This guide covers the economic burden, racial and income disparities, productivity losses, and evidence-based interventions that reduce both health and financial harm.
A clinical history of NAFLD and MASLD treatment from the 1980s to today, covering lifestyle interventions, vitamin E, pioglitazone, and the first FDA-approved therapy resmetirom, with primary-source citations throughout.
A comprehensive clinical review of racial and ethnic disparities in NAFLD / MASLD prevalence, severity, genetics, and treatment access, with primary-source citations and guidance.
A clinical deep-dive into why Black, Hispanic, Native American, and Pacific Islander adults carry a disproportionate burden of obesity, what drives those gaps, and how current guidelines address them.
A deep dive into the latest OSA mechanism research: loop gain, arousal threshold, upper-airway muscle dysfunction, hypoxic signaling, and GLP-1 pathway discoveries that are reshaping treatment strategy.
A comprehensive clinical history of obstructive sleep apnea treatment from tracheotomy in the 1960s through CPAP, oral appliances, surgery, and the emerging GLP-1 era, with primary-source citations throughout.
Black, Hispanic, Asian, and Native American populations face higher OSA prevalence, later diagnosis, and worse outcomes than white patients. Learn what drives these gaps and what clinicians can do.
A deep look at the emerging biological mechanisms driving perimenopause, including neuroinflammation, mitochondrial dysfunction, and kisspeptin signaling, with primary-source citations and clinical implications.
1.1 mil millones de mujeres estarán en o tras la transición menopáusica para 2025, con 47 millones entrando en perimenopausia cada año.
Perimenopause is an adult phenomenon, but early-onset and adolescent hormonal transitions share overlapping biology. Learn how age shapes diagnosis, symptoms, and treatment across the lifespan.
A look at the most contested questions in post-surgical recovery, from opioid-sparing protocols to optimal nutrition timing, with primary-source citations and practical guidance.
A clinical review of racial and ethnic disparities in post-surgical recovery, covering pain management, complication rates, readmission, and evidence-based strategies to close the gap.
A deep dive into the socioeconomic impact of post-surgical recovery, covering direct medical costs, lost productivity, caregiver burden, and disparities in recovery outcomes across income and insurance strata.
A clinically rigorous review of the most contested debates in prediabetes research: diagnostic thresholds, reversal definitions, treatment with metformin, overdiagnosis risk, and what current guidelines actually recommend.
A clinical deep-dive into how prediabetes treatment has evolved from lifestyle-only advice in the 1980s through modern pharmacotherapy and precision medicine, with primary-source citations and actionable guidance.
Why prediabetes rates differ sharply by race and ethnicity, which populations carry the highest burden, and what ADA and USPSTF guidelines recommend for equitable screening and treatment.
A clinical review of racial and ethnic disparities in secondary hypogonadism diagnosis, treatment access, and outcomes, with primary-source citations and actionable clinical guidance.
A review of the most contested clinical questions in tendinopathy management, from diagnosis and pathology staging to loading protocols, injections, biologics, and surgery thresholds, with an honest account of where the evidence is solid and where it is not.
An evidence-based review of the emerging biological mechanisms driving tendinopathy, including neurogenic inflammation, failed healing responses, metabolic drivers, and new therapeutic targets backed by primary-source research.
Tendinopathy looks different in children than in adults. Learn how growth plates, collagen maturity, and activity patterns change diagnosis, prognosis, and treatment across age groups, with citations to primary clinical evidence.
A clinical overview of the socioeconomic burden of tendinopathy, covering direct medical costs, productivity losses, disability rates, and evidence-based management strategies that reduce long-term expenses.
A comprehensive, evidence-based review of how race and ethnicity shape type 2 diabetes risk, diagnosis, complications, and treatment access, with primary-source citations throughout.
A clinically grounded review of the socioeconomic burden of type 2 diabetes, direct medical costs, lost productivity, racial and income disparities, and actionable strategies backed by primary trial and guideline data.
Randomized trials from 2011-2015 show myo-inositol restores ovulation in up to 62% of PCOS patients versus 27% on placebo, rivaling metformin.